HistoSonics Secures Coverage for Liver Tumor Treatment for 7M Highmark BCBS Members

HistoSonics Secures Coverage for Liver Tumor Treatment for 7M Highmark BCBS Members

HistoSonics, the manufacturer of the Edison Histotripsy System, on July 14, announced that Highmark Blue Cross Blue Shield has issued four new positive medical policy decisions for the use of histotripsy in the treatment of liver tumours. The decision expands insurance coverage across Highmark’s commercial plans across four states, including New York, Delaware, Pennsylvania, and West Virginia, broadening access to HistoSonics’ non-invasive thera…

HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 7 Million Blue Cross Blue Shield Highmark Members

Coverage for Histotripsy of Liver Tumors Now Includes Members in New York, Delaware, Pennsylvania, and West VirginiaMINNEAPOLIS--(BUSINESS WIRE)--#HistoSonics--HistoSonics, the manufacturer of the Edison® Histotripsy System, today announced that Highm... L'articolo HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 7 Million Blue Cross Blue Shield Highmark Members è un contenuto originale di 01net.